Lung Function in Patients with Asthma With and Without CRSwNP1
ppFEV1 and FEV1/FVC were significantly lower in patients with asthma and CRSwNP than in patients without CRSwNP1,a
Post-surgical Nasal Polyps Recurrence2
Comorbidities, including asthma, were associated with recurrence of nasal polyps post-surgery in patients with CRSwNP (N=299)2,b
SCS Use in Patients with CRSwNP alone vs CRSwNP and Asthma3
CRSwNP
All-cause
SCS use
All-cause
SCS use
61.9%
Asthma + CRSwNP
All-cause
SCS use
All-cause
SCS use
75.2%
CRSwNP
CRSwNP-related
SCS use
CRSwNP-related
SCS use
39.4%
Asthma + CRSwNP
CRSwNP-related
SCS use
CRSwNP-related
SCS use
47.0%
Significantly*** more patients with asthma and CRSwNP required SCS than those with CRSwNP only (N=21,172)3,c
Type 2 inflammation can be a key driver of increased clinical burden in patients with coexisting asthma and CRSwNP4